02 Jul 2026
A&O Shearman advises Prosus on investment in Alan
"A&O Shearman advised Prosus as lead investor on a €480m funding round for health insurer Alan, with Prosus contributing €400m and valuing the company at €5.5bn. Osler, Hoskin & Harcourt LLP provided Canadian due diligence support and Orrick advised Alan. Proceeds will fund Alan’s international expansion and technology deployment; the transaction remains subject to French regulatory approvals."